Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

Name: Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Published: 2002
License: Public Domain

M.D. Anderson Cancer Center · 2002

ClinicalTrials.gov · Datasets · License: Public Domain · 2002

Open Source ↗

prostate-cancer

metastatic cancer, prostate cancer, recurrent prostate cancer, stage iv prostate cancer, bone metastases, progressive androgen-independent prostate cancer, metastron, sr-89, strontium-89, strontium chloride sr 89, celecoxib, celebrex

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 840923
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.